Replies to post #224205 on Kraig Biocraft Laboratories Inc (KBLB)

[rayovac812]

Reverse-splitting the stock and uplisting to NASDAQ without any spidersilks' sales is unwise and stupid.

How are you with companies then, that aren't selling any drugs and simply have drug candidates? Would you call that stupid? They are already on the NASDAQ and many of them via reverse stock splits. They certainly aren't "perform(ing) the services on selling the spider silks(drugs) and obtaining revenues in a consistence manner."

They do not have their "spider silk" in hand yet. It would be "stupid" for them?

This is why I make these arguments. Stupid could simply be speaking to your personal risk tolerance, or stupid being somehow self evident needs rationalized.

KBLB just needs production, which is easy compared to the risks mentioned above. For the most part, the only problem(s) we could see, have been seen and fixed.....granted not to everyones satisfaction. Silkworms come preprogrammed to do what they do. We just edited the programming.

The outcome is predictable, far more than drugs doing what the makers claim.

[want2retire]

“Using common sense and have some understanding of Business 101 are always helpful than relying on smarts that would be qualified for "999" membership.”

So the insinuation is Kim and his team of advisors and consultants don’t know what is best for the company with their knowledge of the inner workings of the company and expertise in matters such as these?

They would be better served by listening to anonymous board poster opinions?

Makes sense.